Last reviewed · How we verify

placebo for genakumab

Changchun GeneScience Pharmaceutical Co., Ltd. · Phase 3 active Small molecule

placebo for genakumab is a Small molecule drug developed by Changchun GeneScience Pharmaceutical Co., Ltd.. It is currently in Phase 3 development for Rheumatoid Arthritis.

This drug is a placebo, meaning it has no active pharmacological effect.

This drug is a placebo, meaning it has no active pharmacological effect. Used for Rheumatoid Arthritis.

At a glance

Generic nameplacebo for genakumab
SponsorChangchun GeneScience Pharmaceutical Co., Ltd.
ModalitySmall molecule
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

As a placebo, genakumab placebo does not interact with any molecular targets or biological pathways. It is used as a control in clinical trials to compare the efficacy of the active drug.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about placebo for genakumab

What is placebo for genakumab?

placebo for genakumab is a Small molecule drug developed by Changchun GeneScience Pharmaceutical Co., Ltd., indicated for Rheumatoid Arthritis.

How does placebo for genakumab work?

This drug is a placebo, meaning it has no active pharmacological effect.

What is placebo for genakumab used for?

placebo for genakumab is indicated for Rheumatoid Arthritis.

Who makes placebo for genakumab?

placebo for genakumab is developed by Changchun GeneScience Pharmaceutical Co., Ltd. (see full Changchun GeneScience Pharmaceutical Co., Ltd. pipeline at /company/changchun-genescience-pharmaceutical-co-ltd).

What development phase is placebo for genakumab in?

placebo for genakumab is in Phase 3.

What are the side effects of placebo for genakumab?

Common side effects of placebo for genakumab include Injection site reaction, Headache, Fatigue.

Related